Company profile
CytoCell fluorescence in situ hybridisation (FISH) | OGT
Choose from over 280 high-quality DNA FISH probes for the detection of genetic aberrations found in cancer and inherited genetic disease. Search now
Updated 06 Jun 2026 16:52
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
PSC05 | Transaction MzUyNTM4OTIzN2FkaXF6a2N4
Published 04 Jun 2026 14:02
CS01 | Transaction MzUyNTM4NzgyOWFkaXF6a2N4
Published 04 Jun 2026 13:52
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jan 2013 to 31 Dec 2015
To develop a new product line of non-human fluorescence in-situ (FISH) probes.
1 Jul 2011 to 31 Dec 2012
High-throughput technologies, such as microarrays or Next Generation Sequencing (NGS), are revolutionising life science research. These technologies are already having an impact on plant and animal breeding, research into crop protection and more importantly in human health. The cost of generating these data is falling, but the ongoing cost of supplying l...
